Announcements

Reagan-Udall Foundation for the FDA Announces New Board Chair; Welcomes New Board Member
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
Read More
Produce Safety Alliance, Critical Path Institute, and Loren A. Eng Recognized with Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.
Read More
Call for Nominations for the 2025 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA (the Foundation) seeks nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
Steven A. Grossman, Jeff Shuren, and the Real-World Evidence Collaborative Recognized with Innovations in Regulatory Science Awards
(October 11, 2024) Steven A. Grossman, JD; Jeff Shuren, MD, JD; and the Real-World Evidence Collaborative will receive the Reagan-Udall Foundation for the FDA’s 2024 Innovations in Regulatory Science Awards on December 10. The prestigious awards…
Read More
Reagan-Udall Foundation for the FDA Publishes RAISE Action Framework to Improve Race and Ethnicity Data Collection in Health Care
(WASHINGTON, July 26, 2024) – The Reagan-Udall Foundation for the FDA (the Foundation) launched a new tool for leaders in health care delivery—the RAISE Action Framework.
Read More
ASH Research Collaborative and Reagan-Udall Foundation for the FDA Launch Sickle Cell Disease Real-World Data Project
(WASHINGTON, April 17, 2024) –The ASH Research Collaborative (ASH RC) and the Reagan-Udall Foundation for the Food and Drug Administration (FDA Foundation) are launching the Real-World Evidence Consortium for Sickle Cell Disease (SCD) to develop…
Read More
Reagan-Udall Foundation for the FDA Announces New Board Leaders, Members
(March 6, 2024) The Reagan-Udall Foundation for the FDA has announced new officers and two new members of its Board of Directors.  Adrian F. Hernandez, MD, MHS, a Board member since 2019, has been elected to serve as the Board’s Vice Chair. Debra…
Read More
Reagan-Udall Foundation for the FDA Announces Hybrid Public Meeting on Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
What: The Reagan-Udall Foundation for the FDA will host a public workshop to explore primary disease activity biomarkers in rare genetic diseases.  Attendees will hear perspectives from patient advocates, researchers, regulators, and…
Read More
Dr. Francis Collins, FDA’s GenomeTrakr, and Representative Diana DeGette and former Representative Fred Upton Recognized with Innovations in Regulatory Science Awards
(December 4, 2023) The Reagan-Udall Foundation for the FDA will present Innovations in Regulatory Science Awards to Francis Collins, MD, GenomeTrakr, and jointly to Representative Diana DeGette (D-CO) and former Representative Fred Upton (R-MI) on…
Read More
Reagan-Udall Foundation for the FDA Names 2023-24 Fellow in Regulatory Science, Innovation, and Health Equity
(August 15, 2023) The Reagan-Udall Foundation for the FDA has selected Kendra Getaw, PharmD, as its 2023-24 Fellow in Regulatory Science, Innovation, and Health Equity. Her year-long role, which began July 2023, includes activities across the…
Read More